Managed Access makes investigational or unapproved treatments available to eligible patients with serious or life-threatening diseases.
As a Novartis Company, Advanced Accelerator Applications is following the Novartis Position on expanded access to Advanced Accelerator Applications Products through Novartis Managed Access Programs (MAPs).
Patients with serious or life-threatening diseases or conditions sometimes seek medical products that are not yet approved or available in their country. Novartis “Managed Access” addresses this need by making certain investigational or unapproved treatments available to eligible patients.
If you need more information or want to submit a request for MAP, please visit the Novartis Managed Access Programs webpage.
139827 7/21